These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1832637)

  • 1. Plasma and CSF levels of dizocilpine (MK-801) required for neuroprotection in the quinolinate-injected rat striatum.
    Willis CL; Brazell C; Foster AC
    Eur J Pharmacol; 1991 Apr; 196(3):285-90. PubMed ID: 1832637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of the mechanisms of delayed neurodegeneration caused by direct injection of quinolinate into the rat striatum in vivo.
    Bakker MH; Foster AC
    Neuroscience; 1991; 42(2):387-95. PubMed ID: 1680225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG; McGeer EG; McGeer PL
    Brain Res; 1989 Mar; 481(2):356-60. PubMed ID: 2524238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evaluation of the role of extracellular amino acids in the delayed neurodegeneration induced by quinolinic acid in the rat striatum.
    Fedele E; Foster AC
    Neuroscience; 1993 Feb; 52(4):911-7. PubMed ID: 8095713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolinic acid neurotoxicity: in vivo increased copper and manganese content in rat corpus striatum after quinolinate intrastriatal injection.
    Santamaría A; Ríos C; Pérez P; Flores A; Galván-Arzate S; Osorio-Rico L; Solís F
    Toxicol Lett; 1996 Oct; 87(2-3):113-9. PubMed ID: 8914619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic treatment with MK-801 increases the quinolinic acid-induced loss of D-1 dopamine receptors in rat striatum.
    Norman AB; Ford LM; Kolmonpunporn M; Sanberg PR
    Eur J Pharmacol; 1990 Feb; 176(3):363-6. PubMed ID: 2139415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats.
    Vezzani A; Serafini R; Stasi MA; Caccia S; Conti I; Tridico RV; Samanin R
    J Pharmacol Exp Ther; 1989 Apr; 249(1):278-83. PubMed ID: 2540317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotoxicity induced by continuous infusion of quinolinic acid into the lateral ventricle in rats.
    Yamada K; Fuji K; Nabeshima T; Kameyama T
    Neurosci Lett; 1990 Oct; 118(1):128-31. PubMed ID: 2147984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential loss of neurochemical markers following quinolinic acid-induced lesions of rat striatum.
    Norman AB; Ford LM; Sanberg PR
    Exp Neurol; 1991 Oct; 114(1):132-5. PubMed ID: 1680744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of neurotensin-containing neurons in the rat striatum. Effects of unilateral striatal lesions with quinolinic acid and ibotenic acid on neurotensin content and its binding site density.
    Masuo Y; Montagne MN; Pélaprat D; Scherman D; Rostène W
    Brain Res; 1990 Jun; 520(1-2):6-13. PubMed ID: 2169955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats.
    Pierozan P; Zamoner A; Soska AK; Silvestrin RB; Loureiro SO; Heimfarth L; Mello e Souza T; Wajner M; Pessoa-Pureur R
    Exp Neurol; 2010 Jul; 224(1):188-96. PubMed ID: 20303347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia.
    Gill R; Brazell C; Woodruff GN; Kemp JA
    Br J Pharmacol; 1991 Aug; 103(4):2030-6. PubMed ID: 1912992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioral evaluation of the anti-excitotoxic properties of MK-801: comparison with neurochemical measurements.
    Susel Z; Engber TM; Chase TN
    Neurosci Lett; 1989 Sep; 104(1-2):125-9. PubMed ID: 2530473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and chronic changes in kynurenate formation following an intrastriatal quinolinate injection in rats.
    Ceresoli-Borroni G; Guidetti P; Schwarcz R
    J Neural Transm (Vienna); 1999; 106(3-4):229-42. PubMed ID: 10392532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MK-801, an N-methyl-D-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum.
    Santamaría A; Ríos C
    Neurosci Lett; 1993 Sep; 159(1-2):51-4. PubMed ID: 8264978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
    Kalonia H; Kumar P; Nehru B; Kumar A
    Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in transition metal contents in rat brain regions after in vivo quinolinate intrastriatal administration.
    Pérez P; Flores A; Santamaría A; Ríos C; Galván-Arzate S
    Arch Med Res; 1996; 27(4):449-52. PubMed ID: 8987176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
    Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
    Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.